Clinical Trial: Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: The Clinical Utility of a Blood-Based Multitranscriptome Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
Brief Summary: The purpose of this study is to evaluate how well an investigational blood test performs. The study will look at the sensitivity and specificity of a blood-based multitranscriptome assay (NETest).
Detailed Summary:
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Current Primary Outcome: Rate of Successful Test Results Per Cohort [ Time Frame: 12 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: H. Lee Moffitt Cancer Center and Research Institute
Dates:
Date Received: October 27, 2016
Date Started: January 2017
Date Completion: December 2018
Last Updated: January 9, 2017
Last Verified: January 2017